1. Home
  2. UEIC vs INMB Comparison

UEIC vs INMB Comparison

Compare UEIC & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$5.28

Market Cap

69.1M

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

BUY

Current Price

$1.43

Market Cap

64.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
UEIC
INMB
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
64.7M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
UEIC
INMB
Price
$5.28
$1.43
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.00
AVG Volume (30 Days)
49.5K
★ 269.7K
Earning Date
11-09-2026
11-06-2026
Dividend Yield
★ 4.58%
N/A
EPS Growth
★ 23.78
11.85
EPS
N/A
★ N/A
Revenue
★ $368,288,000.00
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.51
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 257.14
52 Week Low
$2.69
$1.09
52 Week High
$5.99
$2.60

Technical Indicators

Market Signals
Indicator
UEIC
INMB
Relative Strength Index (RSI) 50.53 27.46
Support Level $3.87 $1.34
Resistance Level $5.80 $1.52
Average True Range (ATR) 0.35 0.11
MACD -0.03 -0.02
Stochastic Oscillator 49.69 5.94

Price Performance

Historical Comparison
UEIC
INMB

About UEIC Universal Electronics Inc.

Universal Electronics Inc is engaged in universal wireless control solutions for the home. The company design, develop, manufacture, ship and support climate control solutions, wireless sensor and smart home control products, home entertainment control products, technology and software solutions and audio-video (AV) accessories that are used by the world's brands in the climate control, security, home automation, home appliance, home entertainment and consumer electronics markets.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: